Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2024-2032

The global prenatal and newborn genetic testing market size reached US$ 6.0 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 16.5 Billion by 2032, exhibiting a growth rate (CAGR) of 11.9% during 2023-2032. The prenatal and newborn genetic testing market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.

Prenatal and Newborn Genetic Testing Market Analysis:

Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.

Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.

Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.

Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.

Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.

Prenatal and Newborn Genetic Testing Market Trends:

High Prevalence of Genetic Diseases in Infants

The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.

Technological advancements

The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.

Increasing awareness and demand

The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.

Prenatal and Newborn Genetic Testing Industry Segmentation:

The report provides an analysis of the key trends in each segment of the prenatal and newborn genetic testing market statistics, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, screening, disease, and end user.

Breakup by Product Type:

Consumables
Instruments

Consumables account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables and instruments. According to the report, consumables represented the largest segment.

Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.

Breakup by Screening:

Non-invasive Prenatal Testing
Chorionic Villus Sampling
Amniocentesis
Maternal Serum Screening

Non-invasive prenatal testing holds the largest share of the industry

A detailed breakup and analysis of the market based on the screening have also been provided in the report. This includes non-invasive prenatal testing, chorionic villus sampling, amniocentesis, and maternal serum screening. According to the report, non-invasive prenatal testing accounted for the largest market share.

NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.

Breakup by Disease:

Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia

Downs syndrome represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the disease. This includes downs syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. According to the report, downs syndrome represented the largest segment.

The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.

Breakup by End User:

Hospital
Maternity and Specialty Clinics
Diagnostic Centers

Hospital represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital, maternity and specialty clinics, and diagnostic centers. According to the report, hospital represented the largest segment.

Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.

Breakup by Region:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America leads the market, accounting for the largest prenatal and newborn genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.

Leading Key Players in the Prenatal and Newborn Genetic Testing Industry:

The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories
BGI Group
Bio-Rad Laboratories Inc.

F. Hoffmann-La Roche AG
Illumina Inc.

Laboratory Corporation of America Holdings
Natera Inc.

PerkinElmer Inc.

Quest Diagnostics Incorporated
Ravgen Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

April 2, 2024: Abbott Laboratories received FDA approval for the TriClip™ transcatheter edge-to-edge repair (TEER) system that's designed for the treatment of tricuspid regurgitation (TR).

March 3, 2023: BGI Group partnered with Science Exchange to offer a 5% discount on its Next Generation Sequencing Services.

April 8, 2024: Bio-Rad Laboratories Inc. announces a collaboration with Allegheny Health Network (AHN), a western Pennsylvania-based integrated healthcare system, to generate clinical evidence across a range of cancer types to support the implementation of Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology for tumor-informed molecular residual disease (MRD) monitoring of patients with solid tumor cancer following curative-intent treatment.

Key Questions Answered in This Report:

How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
What are the key regional markets?
Which countries represent the most attractive prenatal and newborn genetic testing market?
What is the breakup of the market based on the product type?
Which is the most attractive product type in the prenatal and newborn genetic testing market?
What is the breakup of the market based on the screening?
Which is the most attractive screening in the prenatal and newborn genetic testing market?
What is the breakup of the market based on the disease?
Which is the most attractive disease in the prenatal and newborn genetic testing market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the prenatal and newborn genetic testing market?
What is the competitive structure of the market?
Who are the key players/companies in the global prenatal and newborn genetic testing market?